These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27158703)

  • 1. Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.
    Brown C; Livermore DM; Otter JA; Warren RE; Jenks P; Enoch DA; Newsholme W; Oppenheim B; Leanord A; McNulty C; Tanner G; Bennett S; Cann M; Bostock J; Collins E; Peckitt S; Ritchie L; Fry C; Hawkey P; Wilson AP
    J Hosp Infect; 2016 Jan; 92(1):86-7. PubMed ID: 27158703
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidrug-Resistant Gram-Negative Organisms (MDRGNO) Information for patients, relatives and visitors.
    J Hosp Infect; 2016 Jan; 92(1):88-91. PubMed ID: 27158704
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug-Resistant Gram-Negative Organisms (MDRGNO): Information for healthcare workers.
    J Hosp Infect; 2016 Jan; 92(1):92-4. PubMed ID: 27158706
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbapenem-resistant organisms (CRO): Information for patients, relatives and visitors.
    J Hosp Infect; 2016 Jan; 92(1):95-8. PubMed ID: 27158707
    [No Abstract]   [Full Text] [Related]  

  • 5. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic.
    Oliva A; Giacobbe DR; Di Luca M; Miller NS
    Biomed Res Int; 2018; 2018():8905874. PubMed ID: 30671476
    [No Abstract]   [Full Text] [Related]  

  • 7. What's new in the treatment of multidrug-resistant gram-negative infections?
    Mo Y; Lorenzo M; Farghaly S; Kaur K; Housman ST
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):171-181. PubMed ID: 30224228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant organisms (CRO): Information for healthcare workers.
    J Hosp Infect; 2016 Jan; 92(1):99-101. PubMed ID: 27158708
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients.
    Cohen J
    J Antimicrob Chemother; 2013 Mar; 68(3):490-1. PubMed ID: 23152481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin for the treatment of multidrug-resistant infections.
    LaPlante K; Cusumano J; Tillotson G
    Lancet Infect Dis; 2018 Nov; 18(11):1174-1175. PubMed ID: 30507395
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistant gram-negative infections.
    Fraimow H; Nahra R
    Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug-resistant bacteria in hematology patients: emerging threats.
    Tatarelli P; Mikulska M
    Future Microbiol; 2016 Jun; 11():767-80. PubMed ID: 27196948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.
    Tseng WP; Chen YC; Yang BJ; Chen SY; Lin JJ; Huang YH; Fu CM; Chang SC; Chen SY
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1216-1225. PubMed ID: 28870265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
    Avery LM; Nicolau DP
    Expert Opin Investig Drugs; 2018 Apr; 27(4):325-338. PubMed ID: 29611447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major army medical center caring for soldiers wounded in Iraq and Afghanistan.
    Zapor MJ; Erwin D; Erowele G; Wortmann G
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):661-3. PubMed ID: 18593337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monotherapy vs. combined therapy in the treatment of multi-drug resistance gramnegative bacteria].
    Martínez-Sagasti F; González-Gallego MA; Moneo-González A
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():43-6. PubMed ID: 27608313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.